Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	47376
Country	South Korea

Received	2019-03-20 01:42
Peer-Review Started	2019-03-22 09:24
To Make the First Decision	2019-06-05 06:20
Return for Revision	2019-06-27 01:13
Revised	2019-07-18 05:04
Second Decision	2019-08-16 08:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2019-08-21 01:55
Articles in Press	2019-08-21 01:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2019-09-10 08:56
Publish the Manuscript Online	2019-09-12 10:38

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Current status of adjuvant chemotherapy for gastric cancer
Manuscript Source	Invited Manuscript
All Author List	In-Hwan Kim
Funding Agency and Grant Number
Corresponding Author	In-Hwan Kim, MD, PhD, Assistant Professor, Department of Surgery, Catholic University of Daegu School of Medicine, 33, 17-gil, Duryugongwon-ro, Nam-gu, Daegu 42472, South Korea. kih2yk@cu.ac.kr
Key Words	Gastric cancer; Adjuvant chemotherapy; Perioperative chemotherapy; Chemoradiotherapy; Guidelines;
Core Tip	There are differences in preferred adjuvant therapy for gastric cancer according to the guidelines from different countries. These include the National Comprehensive Cancer Network recommending chemoradiotherapy, the European Society for Medical Oncology recommending perioperative chemotherapy, and the Japanese recommending postoperative chemotherapy. Understanding the differences between guidelines can help in the future investigations of further regimens for adjuvant treatment of gastric cancer.
Publish Date	2019-09-12 10:38
Citation	Kim IH. Current status of adjuvant chemotherapy for gastric cancer. World J Gastrointest Oncol 2019; 11(9): 679-685
URL	https://www.wjgnet.com/1948-5204/full/v11/i9/679.htm
DOI	https://dx.doi.org/10.4251/wjgo.v11.i9.679

Full Article (PDF)	WJGO-11-679.pdf
Full Article (Word)	WJGO-11-679.docx
Manuscript File	47376-Review.docx
Answering Reviewers	47376-Answering reviewers.pdf
Audio Core Tip	47376-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	47376-Conflict-of-interest statement.pdf
Copyright License Agreement	47376-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	47376-Language certificate.pdf
Peer-review Report	47376-Peer-review(s).pdf
Scientific Misconduct Check	47376-Scientific misconduct check.pdf
Scientific Editor Work List	47376-Scientific editor work list.pdf